Corey Davis | LifeSci Advisors |
Glenn Mattes | President & Chief Executive Officer |
Dale Christensen | Director of Clinical Development |
Kirk Coleman | Chief Financial Officer |
Bill Williams | University of Texas, Austin |
Chris Cano | Chief Operating Officer & Head of Business Development |
Jonathan Aschoff | ROTH Capital Partners |
Michael Okunewitch | Maxim Group |
Sahil Kazmi | B. Riley Securities |
Daniel Carlson | TW Research Group |
Richard Deutsch | National Securities |
Good afternoon, ladies and gentlemen, and welcome to the TFF Pharmaceuticals Second Quarter 2021 Financial Results Conference Call.
As a reminder, this conference is being recorded. I will now turn the call over to our host Corey Davis of LifeSci Advisors.
You may begin your conference.
Thank you, operator.